our products
Contact phone

Azilect

Alzheimer's And Parkinson's Azilect (Generic) Generic drugs, marketed without brand names, contain the exact same active ingredients used in their brand-name counterparts, but cost significantly less. The drugs are required to meet US Food and Drug Administration (FDA) standards for safety, purity and effectiveness.
Azilect

MAO-B is an enzyme that breaks down monoamines, and azilect blocks that enzyme. It accomplishes its purpose by elevating particular chemical concentrations in the brain. The symptoms of Parkinson's disease can be managed using the medication Azilect (stiffness, tremors, spasms, poor muscle control). Levodopa is another medication that is occasionally used with azilect in treatment.

BEST DEAL!

Save 20% with

Coupon "PKVCbYFj9G"

Product Options

Qty Price Per pill Savings
30 tablet $ 0.00

Best Deal

$ 0.00
Sold out
60 tablet $ 0.00

Best Deal

$ 0.00 -
Sold out
90 tablet $ 0.00

Best Deal

$ 0.00 -
Sold out
120 tablet $ 0.00

Best Deal

$ 0.00 -
Sold out
180 tablet $ 0.00

Best Deal

$ 0.00 -
Sold out
Qty Price Per pill Savings
30 tablet $ 0.00

Best Deal

$ 0.00
Sold out
60 tablet $ 0.00

Best Deal

$ 0.00 -
Sold out
90 tablet $ 0.00

Best Deal

$ 0.00 -
Sold out
120 tablet $ 0.00

Best Deal

$ 0.00 -
Sold out
180 tablet $ 0.00

Best Deal

$ 0.00 -
Sold out

Exploring the Benefits of Rasagiline: A Breakthrough in Parkinson's Disease Treatment

Introduction

Parkinson's disease is a neurodegenerative disorder that affects millions of people worldwide. It is characterized by the progressive loss of dopamine-producing cells in the brain, leading to a wide range of motor and non-motor symptoms. Over the years, researchers have been diligently working to find effective treatments to alleviate the symptoms and slow down the progression of this debilitating disease. One such breakthrough in Parkinson's disease treatment is Rasagiline, a medication that has shown promising results in managing the symptoms and improving the quality of life for patients.

Understanding Rasagiline and its Mechanism of Action

Rasagiline, also known by its brand name Azilect, is a selective monoamine oxidase-B (MAO-B) inhibitor. MAO-B is an enzyme that breaks down dopamine in the brain, and by inhibiting its activity, Rasagiline helps maintain higher levels of dopamine, which is essential for normal motor function. This medication has been approved by regulatory authorities for the treatment of Parkinson's disease, either as monotherapy or in combination with other medications.

Benefits of Rasagiline in Parkinson's Disease Management

Rasagiline offers several benefits in the management of Parkinson's disease. Firstly, it helps to improve motor symptoms such as tremors, stiffness, and bradykinesia. By increasing dopamine levels in the brain, Rasagiline helps restore balance and coordination, allowing patients to regain control over their movements. Additionally, this medication has been shown to reduce "off" time, which refers to the periods when Parkinson's symptoms are not adequately controlled by medication. By minimizing these "off" periods, Rasagiline provides a more consistent relief from symptoms throughout the day.

Conclusion

In conclusion, Rasagiline has emerged as a valuable addition to the treatment options available for individuals living with Parkinson's disease. Its ability to improve motor symptoms and reduce "off" time has had a significant positive impact on the quality of life for patients. However, it's important to note that Rasagiline may not be suitable for everyone, and it should always be prescribed and monitored by a healthcare professional. As research continues to unfold, we hope to see further advancements in Parkinson's disease treatment, bringing us closer to a cure and a better future for those affected by this condition.

Testimonials

high quality medications

Free discreet shipping

Secure online transactions

Money-back guarantee

Fast worldwide delivery

By staying on our site you automatically agree with the storage and processing of your personal data, in accordance with our Privacy Policy.